Extracellular tau oligomers, recombinant or extracted from AD brains or naturally produced from hTau mice, effectively and consistently induce key features of AD including synaptic dysfunction and memory loss, whereas tau monomers produce no deleterious effects. This evidence concerns the gene MAPT and Alzheimer disease.